A detailed history of Focus Financial Network Inc /Adv transactions in Biogen Inc. stock. As of the latest transaction made, Focus Financial Network Inc /Adv holds 2,777 shares of BIIB stock, worth $443,847. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,777
Holding current value
$443,847
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$222.59 - $267.94 $618,132 - $744,069
2,777 New
2,777 $719 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Focus Financial Network Inc /Adv Portfolio

Follow Focus Financial Network Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network Inc /Adv with notifications on news.